Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 7440-63-3
2. Xe
3. Xenon Atom
4. Chebi:49957
5. Xenon (jan)
6. 3h3u766w84
7. 20222-53-1
8. Xenon [jan]
9. Einecs 231-172-7
10. Un2036
11. Un2591
12. Xenon Dihydride
13. Xenon Hydride
14. Unii-3h3u766w84
15. Xenon, Compressed
16. Xenopure (tn)
17. Xenon(0)
18. Xenon [vandf]
19. Xenon 99+%
20. Xenon [who-dd]
21. Xenon [mart.]
22. Xenon [mi]
23. [xe]
24. 54xe
25. Xenon,isotope Of Mass 123
26. Chembl1236802
27. Dtxsid5064700
28. Chebi:49956
29. Xenon, >=99.995%
30. Mfcd00036280
31. Akos025310455
32. Db13453
33. Xenon, 99.99%, Messer(r) Cangas
34. Q1106
35. D01901
36. Xenon, Refrigerated Liquid (cryogenic Liquids)
37. Xenon, Compressed [un2036] [nonflammable Gas]
38. Xenon, Refrigerated Liquid (cryogenic Liquids) [un2591] [nonflammable Gas]
Molecular Weight | 131.29 g/mol |
---|---|
Molecular Formula | Xe |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 0 |
Exact Mass | 131.90415508 g/mol |
Monoisotopic Mass | 131.90415508 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 1 |
Formal Charge | 0 |
Complexity | 0 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anesthetics, Inhalation
Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)
N - Nervous system
N01 - Anesthetics
N01A - Anesthetics, general
N01AX - Other general anesthetics
N01AX15 - Xenon
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
19
PharmaCompass offers a list of Xenon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Xenon manufacturer or Xenon supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Xenon manufacturer or Xenon supplier.
PharmaCompass also assists you with knowing the Xenon API Price utilized in the formulation of products. Xenon API Price is not always fixed or binding as the Xenon Price is obtained through a variety of data sources. The Xenon Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 00472_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 00472_FLUKA, including repackagers and relabelers. The FDA regulates 00472_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 00472_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 00472_FLUKA supplier is an individual or a company that provides 00472_FLUKA active pharmaceutical ingredient (API) or 00472_FLUKA finished formulations upon request. The 00472_FLUKA suppliers may include 00472_FLUKA API manufacturers, exporters, distributors and traders.
click here to find a list of 00472_FLUKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 00472_FLUKA DMF (Drug Master File) is a document detailing the whole manufacturing process of 00472_FLUKA active pharmaceutical ingredient (API) in detail. Different forms of 00472_FLUKA DMFs exist exist since differing nations have different regulations, such as 00472_FLUKA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 00472_FLUKA DMF submitted to regulatory agencies in the US is known as a USDMF. 00472_FLUKA USDMF includes data on 00472_FLUKA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 00472_FLUKA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 00472_FLUKA suppliers with USDMF on PharmaCompass.
00472_FLUKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 00472_FLUKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 00472_FLUKA GMP manufacturer or 00472_FLUKA GMP API supplier for your needs.
A 00472_FLUKA CoA (Certificate of Analysis) is a formal document that attests to 00472_FLUKA's compliance with 00472_FLUKA specifications and serves as a tool for batch-level quality control.
00472_FLUKA CoA mostly includes findings from lab analyses of a specific batch. For each 00472_FLUKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
00472_FLUKA may be tested according to a variety of international standards, such as European Pharmacopoeia (00472_FLUKA EP), 00472_FLUKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (00472_FLUKA USP).